newsfilter
← Latest News
GlobeNewswire·

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference

CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it